Deterministic, dynamic audience targeting and activation based on predicted brand eligibility, so you can reach every qualified patient at the right time – and avoid limiting geographies due to increasing privacy regulations
Deterministic, dynamic audience targeting and activation based on predicted brand eligibility, so you can reach every qualified patient at the right time – and avoid limiting geographies due to increasing privacy regulations
In today’s world of increasingly scrutinized consumer targeting practices, ballooning marketing costs, and ‘black box’ measurement practices, our patented Micro-Neighborhood® Targeting MNT technology is trusted by over 150 pharmaceutical brands to reach the right patients while addressing current and emerging state regulations.
MNT is just what it sounds like: a way to find and engage your patients with an unparalleled level of clinical precision in hyper-local clusters. As part of the Dynamic Audience Activation Platform (DAAP), MNT now incorporates AI to detect potential brand eligibility within the U.S. population, for the most timely and inclusive targeting approach possible.
Reach and engage more of your ideal patient audiences during key care windows, regardless of where they live or their preferred media - including often underserved areas.
We utilize real-world medical evidence including a vast warehouse of open and closed medical claims, commercial and specialty prescription claims, as well an array of consumer attributes and social determinants of health to identify the key signals of brand eligibility and build a brand-specific AI predictive model.
MNT looks for all patients expressing brand eligibility signals (covering more than 90% of the U.S. population) then scores over 35 million zip-9 geographies based on the concentration of those signals to create a prioritized, highly specific, and privacy-safe audience. Geographies are automatically refreshed and prioritized constantly for maximum marketing relevance and precision.
Unlike static audiences where lower-volume geographics may be cut due to budget constraints, dynamic audience reprioritization provides nationwide scale – focused on reaching each patient during conversion opportunity windows, so each marketing dollar delivers more commercial impact.
Patented tokenization technology associates de-identified prescription and medical claims data to consumer-level data, supporting compliance with HIPAA as well as emerging state regulations.
Real-time scoring and ranking of 35M+ hyperlocal, zip-9 areas based on the concentration of patient / brand eligibility signals, for more relevant, productive media targeting.
Award winning, multi-party data linking technology combines the fidelity of first-party data with the privacy of hashed, third-party identifiers – maintaining data privacy while maximizing targeting precision.
Choose from stand-alone custom audience development, or let our experts be an extension of your internal or agency team.
We’re here to help you capitalize on the latest marketing science. Our patient-centric, patented solutions dynamically segment, prioritize, and engage HCP and consumer audiences, delivering superior performance and script lift.
Bring your brand strategies to life – and deliver incredible results for your clients. We make it easier for our agency partners to incorporate more precise audience targeting and omnichannel delivery into their marketing campaigns.
Increase the effectiveness of your life science customers' brand marketing with custom-built, scalable, and clinically-specific consumer segments. Our privacy-safe technology delivers superior ad performance – and the competitive edge to grow advertising dollars.
Learn more about how data science and technology are driving performance and impact for direct-to-consumer marketing programs.
Drive brand growth with unprecedented predictive audience intelligence and smarter program execution
Let’s talk about your brand marketing needs and how our dynamic, patient-centric solutions help achieve your commercial goals.